BioCardia Inc (BCDA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.08-0.92%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BCDA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.0 | 0.1 | 0.5 | 1.4 | 1.0 | 0.1 | 0.7 | 0.6 | 0.5 | 0.6 | — | — | — | — | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 0.5 | 0.6 | — | — | — | — | 0.0 |
| Cost of Revenues | — | — | — | — | — | 0.0 | 0.0 | 0.4 | 0.5 | — | — | — | — | — | 0.0 | 0.0 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 3.2 | 3.3 | 3.7 | 4.4 | 4.4 | 5.1 | 5.9 | 6.0 | 5.8 | 6.4 | 4.1 | — | — | — | — | — |
| R&D Expenses | 4.2 | 5.0 | 4.4 | 7.7 | 8.8 | 8.6 | 9.8 | 8.6 | 8.5 | 5.8 | 3.3 | — | — | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) |
| Operating Income | (7.4) | (8.3) | (8.0) | (11.6) | (11.9) | (12.6) | (15.5) | (14.2) | (14.1) | (12.4) | (7.6) | (5.4) | 0.2 | 0.0 | (0.3) | (0.6) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.0 | 0.1 | 1.7 | 0.0 | 1.7 | — | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | — | — | (0.0) | (0.0) | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.1 | 0.1 | 0.1 | (0.0) | 0.0 | 0.5 | (0.5) | 0.1 | 0.1 | (2.7) | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | — | — | — | — | — | 0.3 | 0.2 | 0.0 | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | ||||||||||||||||
| Net Income | (7.3) | (8.2) | (7.9) | (11.6) | (11.9) | (12.6) | (15.0) | (14.7) | (14.0) | (12.3) | (10.3) | (6.7) | 0.2 | 0.0 | 0.3 | 9.7 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.61) | (1.23) | (2.90) | (8.19) | (0.67) | (0.75) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 12.1 | 6.7 | 2.7 | 1.4 | 17.7 | 16.9 | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | — | — | — | — | — | — | — | — | — | — | — | 230.3 | 230.3 | 230.3 | 230.3 | 230.3 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (8.3) | (7.9) | (11.6) | (11.8) | (12.6) | (15.5) | (14.1) | (14.0) | (12.3) | (7.6) | — | — | — | — | (0.6) |
| EBIT | (7.4) | (8.3) | (8.0) | (11.6) | (11.9) | (12.6) | (15.5) | (14.2) | (14.1) | (12.4) | (7.6) | (5.4) | 0.2 | 0.0 | (0.3) | (0.6) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.